Insulet shares are trading lower after Barclays maintained an Equal-Weight rating on the stock and lowered its price target from $214 to $213.
Portfolio Pulse from Benzinga Newsdesk
Insulet's stock trades lower as Barclays maintains an Equal-Weight rating but lowers its price target from $214 to $213.
February 26, 2024 | 3:13 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Barclays maintained an Equal-Weight rating on Insulet and reduced the price target from $214 to $213, leading to a decrease in stock price.
The reduction in the price target by Barclays, even though slight, signals a less optimistic outlook on Insulet's stock value, potentially leading to a decrease in investor confidence and a short-term negative impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100